Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants
Public ClinicalTrials.gov record NCT05260437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1, Open-label, Safety, Reactogenicity, and Immunogenicity Trial of the CV2CoV mRNA Vaccine Against SARS CoV 2 in Seropositive Adult Participants
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Prevention of COVID-19 caused by SARS-CoV-2.
Study identification
- NCT ID
- NCT05260437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- CV2CoV (2 µg) Biological
- CV2CoV (4 µg) Biological
- CV2CoV (8 µg) Biological
- CV2CoV (12 µg) Biological
- CV2CoV (16 µg) Biological
- CV2CoV (20 µg) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2022 (Actual)
- Primary completion
- Mar 7, 2023 (Actual)
- Completion
- Mar 7, 2023 (Actual)
- Last update posted
- Aug 12, 2024
2022 – 2023
United States locations
- U.S. sites
- 24
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Lynn Institute of Denver - ERN | Aurora | Colorado | 80012-4520 | — |
| GSK Investigational Site | Hallandale | Florida | 33009 | — |
| MD Clinical - Velocity | Hallandale | Florida | 33009 | — |
| GSK Investigational Site | Lakeland | Florida | 33803-5918 | — |
| Accel Research Sites | Lakeland | Florida | 33803 | — |
| GSK Investigational Site | Miami | Florida | 33173 | — |
| Suncoast Research Group LLC - ERN-PPDS | Miami | Florida | 33173 | — |
| GSK Investigational Site | Palm Springs | Florida | 33406 | — |
| Affinity Health Corp | Oak Brook | Illinois | 60523 | — |
| GSK Investigational Site | Oak Brook | Illinois | 60523 | — |
| GSK Investigational Site | Cleveland | Ohio | 44122 | — |
| Velocity Clinical Research - Cleveland | Cleveland | Ohio | 44122 | — |
| GSK Investigational Site | Norman | Oklahoma | 73072 | — |
| Lynn Institute of Norman - ERN - PPDS | Norman | Oklahoma | 73072 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| GSK Investigational Site | Cedar Park | Texas | 78613 | — |
| GSK Investigational Site | Dallas | Texas | 75203-1259 | — |
| GSK Investigational Site | Dallas | Texas | 75234 | — |
| Research Your Health - Elite | Plano | Texas | 75093 | — |
| DM Clinical - Cyfair Clinical Research Center | Tomball | Texas | 77375 | — |
| GSK Investigational Site | Tomball | Texas | 77375 | — |
| GSK Investigational Site | West Jordan | Utah | 84088 | — |
| Velocity Clinical Research - Salt Lake City - Jordan Valley-ERN-PPDS | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05260437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2024 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05260437 live on ClinicalTrials.gov.